Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2021 1
2022 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
In vitro activity of Ceftazidime-Avibactam and its comparators against Carbapenem resistant Enterobacterales collected across India: results from ATLAS surveillance 2018 to 2019.
Bakthavatchalam YD, Routray A, Mane A, Kamat S, Gupta A, Bari AK, Rohit A, Poojary A, Mukherjee DN, Sethuraman N, Munshi N, Shah S, Balaji V, Gupta Y. Bakthavatchalam YD, et al. Among authors: mukherjee dn. Diagn Microbiol Infect Dis. 2022 May;103(1):115652. doi: 10.1016/j.diagmicrobio.2022.115652. Epub 2022 Jan 31. Diagn Microbiol Infect Dis. 2022. PMID: 35255290 Free article.
Behavioral and physiological toxicity thresholds of a freshwater vertebrate (Heteropneustes fossilis) and invertebrate (Branchiura sowerbyi), exposed to zinc oxide nanoparticles (nZnO): A General Unified Threshold model of Survival (GUTS).
Saha S, Chukwuka AV, Mukherjee D, Dhara K, Saha NC, Faggio C. Saha S, et al. Among authors: mukherjee d. Comp Biochem Physiol C Toxicol Pharmacol. 2022 Dec;262:109450. doi: 10.1016/j.cbpc.2022.109450. Epub 2022 Sep 1. Comp Biochem Physiol C Toxicol Pharmacol. 2022. PMID: 36058464
Distinctive Mobile Genetic Elements Observed in the Clonal Expansion of Carbapenem-Resistant Klebsiella pneumoniae in India.
Shankar C, Jacob JJ, Sugumar SG, Natarajan L, Rodrigues C, Mathur P, Mukherjee DN, Sharma A, Chitnis DS, Bharagava A, Manesh A, Gunasekaran K, Veeraraghavan B. Shankar C, et al. Among authors: mukherjee dn. Microb Drug Resist. 2021 Aug;27(8):1096-1104. doi: 10.1089/mdr.2020.0316. Epub 2021 Mar 15. Microb Drug Resist. 2021. PMID: 33720791
Treatment challenges in the management of difficult-to-treat gram-positive infections: A consensus view apropos therapeutic role of novel anti-MRSA antibiotics, levonadifloxacin (IV) and alalevonadifloxacin (oral).
Saseedharan S, Dubey D, Singh RK, Zirpe K, Choudhuri AH, Mukherjee DN, Gupta N, Sahasrabudhe S, Soni S, Kulkarni S, Walse P, Vora AC, Thomas J, Tayade A, Bhadarke G, Kishore K, Paliwal Y, Patil P, Reddy PK, Nagvekar V, Veeraraghavan B. Saseedharan S, et al. Among authors: mukherjee dn. Indian J Med Microbiol. 2024 Jan-Feb;47:100528. doi: 10.1016/j.ijmmb.2024.100528. Epub 2024 Jan 21. Indian J Med Microbiol. 2024. PMID: 38228227